3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
13
Myelodysplastic Syndromes
6
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Advanced Solid Tumour
3
Small Cell Lung Carcinoma
2
Recurrence
2
Multiple Myeloma
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Breast Cancer
2
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Idiopathic Pulmonary Fibrosis
1
Esophageal Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Depression
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Blast Crisis
1
Interventions
Cyclophosphamide
5
fludarabine phosphate
3
Vincristine
3
Methotrexate
3
Etoposide
3
pegaspargase
2
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Leucovorin
2
Doxorubicin
2
Dexamethasone
2
Cytarabine
2
Calcium Dobesilate
2
venetoclax
1
prednylidene
1
hydrocortisone hemisuccinate
1
fludarabine
1
exifone
1
deltacortene
1
calaspargase pegol
1
azathiopurine
1
aldesleukin
1
Thioguanine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
Injections
×
30 days
×
Clear all
No trials found.